呼吸道和心血管药物暴露对肺功能轨迹的影响
Xander Bertels1,2, Delphine Vauterin1, Sebastian Riemann3,4
1Ghent University, Department of Bioanalysis, Gent, Belgium.
Annals of the American Thoracic Society
|September 23, 2024
概括
某些呼吸和心血管药物,包括长效β2-激动剂 (LABA),吸入性皮质类固醇 (ICS) 和他类药物,可以改善肺功能轨迹. 然而,开始服用β1抑制剂与加速的肺功能下降有关.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
背景情况:
- 肺功能下降是成年人的一个重大问题.
- 呼吸道和心血管药物治疗是缓解这种衰退的潜在干预措施.
研究的目的:
- 调查各种呼吸道和心血管药物对一般成年人群肺功能轨迹的影响.
- 探索遗传变异对药物疗效的影响.
主要方法:
- 使用了来自鹿特丹研究 (成人≥45岁) 的螺旋计数据.
- 对长效β2-激动剂 (LABA),长效肌抗体 (LAMA),吸入性皮质类固醇 (ICS),β阻断剂,通道阻断剂,ACE抑制剂,血管新生素II受体阻断剂和他类药物的量化暴露.
- 雇佣的倾向-得分匹配和多项逻辑回归,按遗传变异分层.
主要成果:
- 长效β2-激动剂 (LABA),吸入性皮质类固醇 (ICS) 和他类药物与改善肺功能轨迹的几率增加有关.
- 开始服用β1抑制剂与较高的快速肺功能下降的几率相关.
- 药物遗传学分析表明,LABA,ICS和β1抑制剂的作用受到其点的遗传变异的影响.
结论:
- 长效β2-激动剂 (LABA),吸入性皮质类固醇 (ICS) 和他类药物显示出有利于调节肺功能的潜力.
- 开始服用β1抑制剂可能与成年人肺功能加速下降有关.
- 遗传因素在对这些药物治疗的反应中发挥着作用.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
360
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
360
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
48
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
48
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
241
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
241
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
COPD: Pathogenesis and Clinical Features
243
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
243


